434 Fayetteville St.,Suite 500
Raleigh , NC, 27601

Rank

Rank Universe

Summary

The fund seeks maximum total return in the long term by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team focuses on securities of foreign (non-U.S.) companies, and primarily invests in inter More

Link

Directors

Dec 11, 2023
  • Douglas R. Van Scoy
  • Alan G. Priest
  • Laura C. Bingham
  • Drew T. Kagan
  • David L. Wedding
  • Scott A. Haenni
  • Kimberly R. Storms

Chief Compliance Officer

  • Charles A. Durham

Fund Manager(s)

  • Robert Bridges
  • Robert Weller

Price

  • $ 9.96 ( +0.05 )
    Dec 24, 2024
    Last Close
  • Net Assets
  • $127.1M
    Feb 23, 2024
  • Holding
  • 111
    Aug 21, 2024
    More

  • 52-Week High/Low
  • $10.83 - $9.35
  • Turnover
  • 126%
  • Expense Ratio
  • 0.93%

Company Name

Holding

Novartis AG 2.31 %
Sanofi SA 1.53 %
ITOCHU Corp 1.49 %
Deutsche Telekom AG 1.39 %
Intesa Sanpaolo SpA 1.39 %
UniCredit SpA 1.33 %
Mitsui & Co Ltd 1.31 %
Holcim AG 1.27 %
Mitsubishi Corp 1.27 %
GSK PLC 1.26 %
More 1.26 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

4.84%

5 Year

-2.64%

Best

26.78%

2017

Worst

-18.22%

2018

Alpha

SBIAX S&P 500

Chart +